AAAAAA

   
Results: 1-14 |
Results: 14
The behavioral effects of acute and chronic JL 13, a putative antipsychotic, in Cebus non-human primates
Authors: Casey, DE Bruhwyler, J Delarge, J Geczy, J Liegeois, JF
Citation: De. Casey et al., The behavioral effects of acute and chronic JL 13, a putative antipsychotic, in Cebus non-human primates, PSYCHOPHAR, 157(3), 2001, pp. 228-235
Effects of benztropine on ketamine-induced behaviors in Cebus monkeys
Authors: Shiigi, Y Casey, DE
Citation: Y. Shiigi et De. Casey, Effects of benztropine on ketamine-induced behaviors in Cebus monkeys, BEHAV PHARM, 12(4), 2001, pp. 293-298
Healthy outcomes in schizophrenia - Introduction
Authors: Murray, R Casey, DE
Citation: R. Murray et De. Casey, Healthy outcomes in schizophrenia - Introduction, INT CLIN PS, 16, 2001, pp. NIL_4-NIL_4
Barriers to progress - the impact of tolerability problems
Authors: Casey, DE
Citation: De. Casey, Barriers to progress - the impact of tolerability problems, INT CLIN PS, 16, 2001, pp. S15-S19
Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate
Authors: Fontaine, KR Heo, M Harrigan, EP Shear, CL Lakshminarayanan, M Casey, DE Allison, DB
Citation: Kr. Fontaine et al., Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate, PSYCHIAT R, 101(3), 2001, pp. 277-288
Clinical trial design issues in schizophrenic research
Authors: Casey, DE
Citation: De. Casey, Clinical trial design issues in schizophrenic research, J CLIN PSY, 62, 2001, pp. 17-22
The pharmacology of weight gain with antipsychotics
Authors: Casey, DE Zorn, SH
Citation: De. Casey et Sh. Zorn, The pharmacology of weight gain with antipsychotics, J CLIN PSY, 62, 2001, pp. 4-10
Antipsychotic-induced weight gain: A review of the literature
Authors: Allison, DB Casey, DE
Citation: Db. Allison et De. Casey, Antipsychotic-induced weight gain: A review of the literature, J CLIN PSY, 62, 2001, pp. 22-31
Update on tardive dyskinesia
Authors: Casey, DE
Citation: De. Casey, Update on tardive dyskinesia, J CLIN PSY, 61, 2000, pp. 3-4
Tardive dyskinesia: Pathophysiology and animal models
Authors: Casey, DE
Citation: De. Casey, Tardive dyskinesia: Pathophysiology and animal models, J CLIN PSY, 61, 2000, pp. 5-9
Antipsychotic standard of care: Redefining the definition of atypical antipsychotics - Introduction
Authors: Casey, DE
Citation: De. Casey, Antipsychotic standard of care: Redefining the definition of atypical antipsychotics - Introduction, J CLIN PSY, 61, 2000, pp. 3-3
Behavioral effects of ketamine, an NMDA glutamatergic antagonist, in non-human primates
Authors: Shiigi, Y Casey, DE
Citation: Y. Shiigi et De. Casey, Behavioral effects of ketamine, an NMDA glutamatergic antagonist, in non-human primates, PSYCHOPHAR, 146(1), 1999, pp. 67-72
Tardive dyskinesia and atypical antipsychotic drugs
Authors: Casey, DE
Citation: De. Casey, Tardive dyskinesia and atypical antipsychotic drugs, SCHIZOPHR R, 35, 1999, pp. S61-S66
Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapy
Authors: Dienstag, JL Schiff, ER Mitchell, M Casey, DE Gitlin, N Lissoos, T Gelb, LD Condreay, L Crowther, L Rubin, M Brown, N
Citation: Jl. Dienstag et al., Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapy, HEPATOLOGY, 30(4), 1999, pp. 1082-1087
Risultati: 1-14 |